Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.59 |
| ▸ | GAA | P10253 | 6/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | ATM | Q13315 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.57 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9850923 | 0.88 | CYP2C9 (0.57) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL5610697 | 0.83 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL4447310 | 0.82 | ALDH1A1 (0.59) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL39559 | 0.81 | ALDH1A1 (0.63) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL284696 | 0.81 | ALDH1A1 (0.63) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL39434 | 0.79 | HSPA5 (0.74) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL42656 | 0.79 | ALDH1A1 (0.64) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL526641 | 0.79 | ALDH1A1 (0.61) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL5609403 | 0.78 | ALDH1A1 (0.50) | ALDH1A1GAATSHRLMNAMAPK1 | |
| SCHEMBL10719480 | 0.77 | ALDH1A1 (0.59) | ALDH1A1GAATSHRLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1885533-A2 | METHOD FOR IMPREGNATING LIGNOCELLULOSIC MATERIALS WITH EFFECT AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-13 | — | — | EP | disclosed |
| US-7199139-B2 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| WO-2006117162-A2 | METHOD FOR IMPREGNATING LIGNOCELLULOSIC MATERIALS WITH EFFECT AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-09 | — | — | WO | disclosed |
| EP-1354602-B1 | MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT | SANKYO CO (JP) | 2006-10-04 | — | — | EP | disclosed |
| EP-1695716-A2 | Medicinal compositions containing diuretics and insulin sensitizers | Sankyo Company, Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20050288339-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2005-12-29 | — | — | US | disclosed |
| EP-1529830-A1 | Ashless additive formulations suitable for hydraulic oil applications | Chevron Oronite S.A. (FR) | 2005-05-11 | — | — | EP | disclosed |
| US-20050096236-A1 | Ashless additive formulations suitable for hydraulic oil applications | CHEVRON ORONITE S.A. | 2005-05-05 | — | — | US | disclosed |
| EP-1451275-A4 | SULFUR CONTAINING LUBRICATING OIL ADDITIVE SYSTEM PARTICULARLY USEFUL FOR NATURAL GAS FUELED ENGINES | CHEVRON ORONITE CO (US) | 2005-03-16 | — | — | EP | disclosed |
| EP-1451275-A1 | SULFUR CONTAINING LUBRICATING OIL ADDITIVE SYSTEM PARTICULARLY USEFUL FOR NATURAL GAS FUELED ENGINES | Chevron Oronite Company LLC (US) | 2004-09-01 | — | — | EP | disclosed |
| EP-0290391-A2 | Polyolefines stabilized against light degradation | CIBA-GEIGY AG (CH) | 1988-11-09 | — | — | EP | disclosed |
| EP-0253773-A2 | Stabilized synthetic polymer | CIBA-GEIGY AG (CH) | 1988-01-20 | — | — | EP | disclosed |
| EP-0252877-A1 | Synergistic stabilizing mixture | CIBA-GEIGY AG (CH) | 1988-01-13 | — | — | EP | disclosed |
| EP-0252003-A2 | Substituted aminoxy succinates and their application as stabilisers | CIBA-GEIGY AG (CH) | 1988-01-07 | — | — | EP | disclosed |
| EP-0249577-A2 | Long chain-(4-hydroxyphenyl)propionate derivatives as stabilizers | CIBA-GEIGY AG (CH) | 1987-12-16 | — | — | EP | disclosed |
| EP-0244362-A2 | Compositions stabilized by aminoxysilanes | CIBA-GEIGY AG (CH) | 1987-11-04 | — | — | EP | disclosed |
| EP-0244355-A2 | Compositions stabilized with substituted aminocarbamates, and substituted aminocarbamates | CIBA-GEIGY AG (CH) | 1987-11-04 | — | — | EP | disclosed |
| EP-0241427-A2 | Compositions stabilised with di- or trisubstituted hydroxylamines and new di- or trisubstituted hydroylamines | CIBA-GEIGY AG (CH) | 1987-10-14 | — | — | EP | disclosed |
| EP-0240463-A2 | Substituted aminooxypropion amides | CIBA-GEIGY AG (CH) | 1987-10-07 | — | — | EP | disclosed |
| EP-0228994-A1 | Substituted aminoxyethylsulfoxides and -sulfones | CIBA-GEIGY AG (CH) | 1987-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288339-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | GPR119, INSR, IRS1 | ALDH1A1 2128/4885GAA 818/4885TSHR 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.